Ubenimex Clinical Study

»»Ubenimex Clinical Study
Ubenimex Clinical Study 2017-06-15T23:09:42+00:00

About the Phase 2 ULTRA Study:

ULTRA is a multi-center, randomized, double-blind, placebo-controlled Phase 2 study of ubenimex in patients with secondary lymphedema of the lower limb(s).  Up to forty patients may be randomized in a 1:1 ratio to receive ubenimex or matching placebo, administered orally for a total of 24 weeks.  The study will assess clinical, biomarker, histologic and patient-reported outcomes.  See clinicaltrials.gov: NCT02700529.

Lymphedema

Pulmonary Arterial Hypertension